Recruiting Neuromyelitis Optica Studies in Parque Patricios
About Neuromyelitis Optica Clinical Trials in Parque Patricios
Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune disease that primarily attacks the optic nerves and spinal cord, causing vision loss and paralysis. It is distinct from multiple sclerosis and often involves aquaporin-4 antibodies. Treatment includes immunosuppressive therapies and biologics.
There are currently 1 neuromyelitis optica clinical trials recruiting participants in Parque Patricios, CIUDAD%20AUT%C3%B3NOMA%20DE%20BUENOSAIRES. These studies are seeking a combined 15 participants. Research is being sponsored by Amgen. Clinical trial participation is free and participants receive study-related medical care at no cost.
Neuromyelitis Optica Clinical Trials in Parque Patricios — FAQ
Are there neuromyelitis optica clinical trials in Parque Patricios?
Yes, there are 1 neuromyelitis optica clinical trials currently recruiting in Parque Patricios, CIUDAD%20AUT%C3%B3NOMA%20DE%20BUENOSAIRES. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Parque Patricios?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Parque Patricios research site will contact you about next steps.
Are clinical trials in Parque Patricios free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Parque Patricios studies also compensate for your time and travel.
What neuromyelitis optica treatments are being tested?
The 1 active trials in Parque Patricios are testing new therapies including novel drugs, biologics, and treatment approaches for neuromyelitis optica.
Data updated March 2, 2026 from ClinicalTrials.gov